Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Amgen unveiled test results Wednesday that suggest it could have one of the first immune-modulating treatments for Sjogren’s disease.
The post Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren’s Data appeared first on Investor’s Business Daily.